Jennifer Lapierre

Title: Innovations in Clinical Genetics by Jennifer Lapierre

Introduction

Jennifer Lapierre is an accomplished inventor based in San Juan Capistrano, California. She has made significant contributions to the field of human clinical genetics through her innovative work. Her research focuses on developing methods to assess the clinical significance of genetic variants, which is crucial for understanding genetic disorders.

Latest Patents

Jennifer Lapierre holds a patent for a "Pathogenicity scoring system for human clinical genetics." This patent outlines methods and systems for determining the clinical significance of a genetic variant. The process involves calculating various scores, including a function score, frequency score, co-occurrence score, and family segregation score. These scores are aggregated using computer systems to generate a clinical significance score that indicates the relevance of the genetic variant.

Career Highlights

Jennifer is currently employed at Athena Diagnostics, Inc., where she continues to advance her research in clinical genetics. Her work has the potential to impact the diagnosis and treatment of genetic conditions significantly. With her expertise, she contributes to the understanding of how genetic variants affect human health.

Collaborations

Jennifer collaborates with talented professionals in her field, including Izabela Karbassi and Christopher D Elzinga. These collaborations enhance her research and contribute to the development of innovative solutions in clinical genetics.

Conclusion

Jennifer Lapierre's contributions to the field of clinical genetics through her patent and work at Athena Diagnostics, Inc. highlight her role as a leading inventor in this important area of research. Her innovative methods for assessing genetic variants are paving the way for advancements in medical genetics.